Glycopegylated factor IX
AssigneeNeose Technologies, Inc.
InventorsShawn DeFrees, Robert Bayer, Caryn Bowe, Krishnasamy Panneerselvam
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeose Technologies, Inc.
InventorsShawn DeFrees, Robert Bayer, Caryn Bowe, Krishnasamy Panneerselvam
Estimating the term…
The present invention provides conjugates between Factor IX and PEG moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.
A Factor IX peptide conjugate comprising a glycosyl linking group attached to an amino acid residue of said peptide, said glycosyl linking group comprising a modified sialyl residue having the formula:
A Factor IX peptide conjugate comprising a glycosyl linking group attached to an amino acid residue of said peptide, said glycosyl linking group comprising a modified sialyl residue having the formula:
Dependencies are inferred from the claim text.